VVT Med Inc.

VVTM · V · Healthcare / Medical Devices

0.16CAD-0.01 (-3.03%)

Price History

Full chart

Market Stats

Previous Close0.165

Open0.175

Day Range0.14 – 0.175

52-Week Range0.15 – 0.45

Volume16.00K

Market Cap14.52M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.11

Dividend Yield0.00%

50-Day Avg0.2134

200-Day Avg0.2424

About

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Erez Tetro
Employees8
HeadquartersHasadna 6 st., Kfar Saba, Israel, 4442405, Canada
Websitehttps://www.vvtmed.com

Leadership

Mr. Erez TetroCEO & Director
Mr. Dor SnehCFO & Corporate Secretary
Mr. Gideon VitkonChief of Operations
Ms. Orly EfratyVice President of Global Marketing
Eyal AlonVice President of Global Sales

Financials

Income Statement

Currency: USD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	81.00K	41.00K	492.00K	89.00K
Growth (%)	-	-49.38%	+1100.00%	-81.91%
Cost of Revenue	74.00K	36.00K	118.00K	26.00K
Gross Profit	7.00K	5.00K	374.00K	63.00K
Gross Margin	8.64%	12.20%	76.02%	70.79%
Operating Expense	2.26M	1.75M	1.47M	5.00M
Operating Income	-2.25M	-1.75M	-1.10M	-4.93M
Operating Margin	-2779.01%	-4256.10%	-222.76%	-5544.94%
EBITDA	-2.28M	-1.75M	-537.00K	-3.36M
EBITDA Margin	-2818.52%	-4268.29%	-109.15%	-3776.40%
Net Income	-2.59M	-2.20M	-1.04M	-3.98M
Net Income Margin	-3202.47%	-5356.10%	-211.38%	-4467.42%
R&D	1.12M	333.00K	263.00K	451.00K
R&D as % of Total Revenue	1387.65%	812.20%	53.46%	506.74%
Interest Expense	221.00K	354.00K	401.00K	463.00K
Interest Expense % of Total Revenue	272.84%	863.41%	81.50%	520.22%

Balance Sheet

Currency: USD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	885.00K	889.00K	985.00K	916.00K
Total Liabilities	4.42M	6.25M	7.37M	2.74M
Total Equity	-3.54M	-5.36M	-6.38M	-1.82M
Cash	151.00K	71.00K	104.00K	145.00K
Net Debt	2.75M	4.64M	5.77M	457.00K

Cash Flow

Currency: USD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-1.93M	-1.40M	-911.00K	-3.16M
Financing Cash Flow	1.86M	1.28M	960.00K	3.03M
Capital Expenditure	19.00K	1.00K	0	4.00K
Free Cash Flow	-1.95M	-1.40M	-911.00K	-3.17M
FCF to OCF	100.98%	100.07%	100.00%	100.13%

Earnings

Report Date	Dec 1, 2026
EPS Estimate	-
EPS Actual	-
Surprise	-
Timing	Pre-market

Key Statistics & Ratios

Market Cap14.52M

Enterprise Value16.14M

Trailing P/E0.00

Forward P/E0.00

Price / Sales151.24

Price / Book0.00

EPS-0.11

Book Value-0.035

Revenue (TTM)96.00K

Gross Profit (TTM)-6.00K

EBITDA-3.02M

Profit Margin0.00%

Operating Margin-1724.24%

Return on Equity0.00%

Return on Assets-446.53%

Shares Outstanding72.59M

Shares Float61.09M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jul 31, 2025214:1000
Sep 11, 20201:100
Oct 30, 20151:5